Format

Send to

Choose Destination
Transfus Apher Sci. 2017 Jun;56(3):317-321. doi: 10.1016/j.transci.2017.05.022. Epub 2017 Jun 3.

Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - Literature review and local experience.

Author information

1
Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada. Electronic address: Mohamed.elemary@saskcancer.ca.
2
International Consultancy in Blood Components Quality/Safety Improvement, Audit/Inspection and DDR Strategies, London, UK.
3
Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada.
4
Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada. Electronic address: hadi.goubranmessiha@saskcancer.ca.

Abstract

Transfusion medicine plays a vital role in the supportive care of patients receiving therapy for hematology, oncology and hematopoietic stem cell transplants (HSCT). With advances in therapy with more intensive chemotherapy or radiotherapy, patients usually develop cytopenias and need frequent transfusion support with packed red blood cells, granulocyte transfusion or platelets to support them until they recover from the effect of therapy. HSCT poses unique challenges for transfusion medicine, since transplant recipients may require substantial transfusion support due to cytopenias associated with toxic medications, decreased marrow reserve, infection or their malignancy. Transfusion support has many complications, mainly immune mediated and infectious complications. Jehovah's Witness patients deny transfusions of blood products as a therapeutic option and, consequently, management of their disease with chemotherapy and stem cell transplant after myeloablative therapy is quite challenging. This review describes the challenges of transfusion support in managing hemato-oncology and stem cell transplant patients and highlights a local experience in transplanting two Jehovah's Witness patients.

KEYWORDS:

Bloodless; HSCT; Hematology-oncology; Hematopoietic stem cell transplantation; Transfusion; Transfusion-free

PMID:
28642120
DOI:
10.1016/j.transci.2017.05.022
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center